403 related articles for article (PubMed ID: 30042077)
41. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
[TBL] [Abstract][Full Text] [Related]
42. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders.
Quraishi S; David A
Cochrane Database Syst Rev; 2000; (2):CD001470. PubMed ID: 10796442
[TBL] [Abstract][Full Text] [Related]
43. Penfluridol for schizophrenia.
Soares BG; Lima MS
Cochrane Database Syst Rev; 2006 Apr; (2):CD002923. PubMed ID: 16625563
[TBL] [Abstract][Full Text] [Related]
44. Inhaled corticosteroids in children with persistent asthma: effects on growth.
Zhang L; Prietsch SO; Ducharme FM
Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
[TBL] [Abstract][Full Text] [Related]
45. Depot bromperidol decanoate for schizophrenia.
Wong D; Adams CE; David A; Quraishi SN
Cochrane Database Syst Rev; 2004; (3):CD001719. PubMed ID: 15266450
[TBL] [Abstract][Full Text] [Related]
46. The response of subgroups of patients with schizophrenia to different antipsychotic drugs: a systematic review and meta-analysis.
Leucht S; Chaimani A; Krause M; Schneider-Thoma J; Wang D; Dong S; Samara M; Peter N; Huhn M; Priller J; Davis JM
Lancet Psychiatry; 2022 Nov; 9(11):884-893. PubMed ID: 36228647
[TBL] [Abstract][Full Text] [Related]
47. Mortality risk in patients with schizophrenia participating in premarketing atypical antipsychotic clinical trials.
Khan A; Schwartz K; Stern C; Redding N; Kolts RL; Brown WA; Robinson DS
J Clin Psychiatry; 2007 Dec; 68(12):1828-33. PubMed ID: 18162012
[TBL] [Abstract][Full Text] [Related]
48. Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials.
Bhanu C; Nimmons D; Petersen I; Orlu M; Davis D; Hussain H; Magammanage S; Walters K
PLoS Med; 2021 Nov; 18(11):e1003821. PubMed ID: 34752479
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials.
Siafis S; Schneider-Thoma J; Hamza T; Bighelli I; Dong S; Hansen WP; Davis JM; Salanti G; Leucht S
BMJ Open; 2023 Feb; 13(2):e064504. PubMed ID: 36810167
[TBL] [Abstract][Full Text] [Related]
50. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
[TBL] [Abstract][Full Text] [Related]
51. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis.
Leucht S; Corves C; Arbter D; Engel RR; Li C; Davis JM
Lancet; 2009 Jan; 373(9657):31-41. PubMed ID: 19058842
[TBL] [Abstract][Full Text] [Related]
52. Family interventions for relapse prevention in schizophrenia: a systematic review and network meta-analysis.
Rodolico A; Bighelli I; Avanzato C; Concerto C; Cutrufelli P; Mineo L; Schneider-Thoma J; Siafis S; Signorelli MS; Wu H; Wang D; Furukawa TA; Pitschel-Walz G; Aguglia E; Leucht S
Lancet Psychiatry; 2022 Mar; 9(3):211-221. PubMed ID: 35093198
[TBL] [Abstract][Full Text] [Related]
53. Antipsychotic treatment for children and adolescents with schizophrenia spectrum disorders: protocol for a network meta-analysis of randomised trials.
Pagsberg AK; Tarp S; Glintborg D; Stenstrøm AD; Fink-Jensen A; Correll CU; Christensen R
BMJ Open; 2014 Oct; 4(10):e005708. PubMed ID: 25304189
[TBL] [Abstract][Full Text] [Related]
54. Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis.
Leucht S; Chaimani A; Mavridis D; Leucht C; Huhn M; Helfer B; Samara M; Cipriani A; Geddes JR; Davis JM
Neuropsychopharmacology; 2019 Oct; 44(11):1955-1966. PubMed ID: 31212302
[TBL] [Abstract][Full Text] [Related]
55. Antipsychotic drugs and their effects on cognitive function: protocol for a systematic review, pairwise, and network meta-analysis.
Feber L; Peter N; Schneider-Thoma J; Siafis S; Bighelli I; Hansen WP; Prates Baldez D; Salanti G; Keefe RSE; Engel RR; Leucht S
Syst Rev; 2023 Mar; 12(1):54. PubMed ID: 36959619
[TBL] [Abstract][Full Text] [Related]
56. Single-arm meta-analysis of drug response in placebo-controlled versus active-controlled antipsychotic drug trials in schizophrenia.
Dong S; Schneider-Thoma J; Siafis S; Peter N; Leucht S
Eur Neuropsychopharmacol; 2024 Jul; 84():21-26. PubMed ID: 38643697
[TBL] [Abstract][Full Text] [Related]
57. Switching to antipsychotic monotherapy vs. staying on antipsychotic polypharmacy in schizophrenia: A systematic review and meta-analysis.
Matsui K; Tokumasu T; Takekita Y; Inada K; Kanazawa T; Kishimoto T; Takasu S; Tani H; Tarutani S; Hashimoto N; Yamada H; Yamanouchi Y; Takeuchi H
Schizophr Res; 2019 Jul; 209():50-57. PubMed ID: 31182319
[TBL] [Abstract][Full Text] [Related]
58. The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis.
Kopelli E; Samara M; Siargkas A; Goulas A; Papazisis G; Chourdakis M
Psychiatry Res; 2020 Sep; 291():113246. PubMed ID: 32599446
[TBL] [Abstract][Full Text] [Related]
59. Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials.
Tani H; Takasu S; Uchida H; Suzuki T; Mimura M; Takeuchi H
Neuropsychopharmacology; 2020 Apr; 45(5):887-901. PubMed ID: 31770770
[TBL] [Abstract][Full Text] [Related]
60. Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years.
Vermeulen JM; van Rooijen G; van de Kerkhof MPJ; Sutterland AL; Correll CU; de Haan L
Schizophr Bull; 2019 Mar; 45(2):315-329. PubMed ID: 29697804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
